The association between uterine scar defect (niche) and the presence of symptoms.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
08 2023
Historique:
received: 23 02 2023
revised: 07 04 2023
accepted: 18 04 2023
medline: 21 8 2023
pubmed: 6 6 2023
entrez: 5 6 2023
Statut: ppublish

Résumé

Is there association between the presence of a uterine niche and the presence of symptoms? This cross-sectional study was conducted at a single tertiary medical centre. All women who underwent Caesarean section from January 2017 to June 2020 were invited to the gynaecological clinics, and requested to complete a questionnaire regarding symptoms related to the presence of a niche (heavy menstrual bleeding, intermenstrual spotting, pelvic pain, infertility). Transvaginal two-dimensional ultrasonography was performed to assess the uterus and uterine scar characteristics. The primary outcome was defined as the presence of a uterine niche, evaluated by length, depth, residual myometrial thickness (RMT) and ratio between the residual myometrial thickness (RMT) and adjacent myometrial thickness (AMT). Of 524 women who were eligible and scheduled for evaluation, 282 (54%) completed the follow-up; 173 (61.3%) were symptomatic and 109 (38.6%) asymptomatic. Niche measurements, including RMT/AMT ratio, were comparable between the groups. In a sub-analysis of each symptom, heavy menstrual bleeding and intermenstrual spotting were associated with reduced RMT (P = 0.02 and P = 0.04, respectively) compared with women with normal menstrual bleeding. An RMT less than 2.5 mm was significantly more prevalent in women reporting heavy menstrual bleeding (11 [25.6%] versus 27 [11.3%]; P = 0.01] and new infertility (7 [16.3%] versus 6 [2.5%]; P = 0.001]. In logistic regression analysis, infertility was the only symptom associated with an RMT less than 2.5 mm (B = 1.9; P = 0.002). A reduced RMT was found to be associated with heavy menstrual bleeding and intermenstrual spotting, while values below 2.5 mm were also associated with infertility.

Identifiants

pubmed: 37277298
pii: S1472-6483(23)00263-8
doi: 10.1016/j.rbmo.2023.04.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103221

Informations de copyright

Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Aya Mohr-Sasson (A)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.. Electronic address: Mohraya@gmail.com.

Tal Dadon (T)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Ariel Brandt (A)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Maya Shats (M)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Michal Axcelrod (M)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Raanan Meyer (R)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Michal Zajicek (M)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Jigal Haas (J)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Roy Mashiach (R)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH